These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28839265)

  • 1. Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression.
    Li Y; Meeran SM; Tollefsbol TO
    Sci Rep; 2017 Aug; 7(1):9345. PubMed ID: 28839265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
    Li Y; Meeran SM; Patel SN; Chen H; Hardy TM; Tollefsbol TO
    Mol Cancer; 2013 Feb; 12():9. PubMed ID: 23379261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial epigenetic mechanisms and efficacy of early breast cancer inhibition by nutritive botanicals.
    Li Y; Buckhaults P; Cui X; Tollefsbol TO
    Epigenomics; 2016 Aug; 8(8):1019-37. PubMed ID: 27478970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications.
    Meeran SM; Patel SN; Li Y; Shukla S; Tollefsbol TO
    PLoS One; 2012; 7(5):e37748. PubMed ID: 22662208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells.
    Li Y; Yuan YY; Meeran SM; Tollefsbol TO
    Mol Cancer; 2010 Oct; 9():274. PubMed ID: 20946668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic reactivation of p21CIP1/WAF1 and KLOTHO by a combination of bioactive dietary supplements is partially ERα-dependent in ERα-negative human breast cancer cells.
    Sinha S; Shukla S; Khan S; Tollefsbol TO; Meeran SM
    Mol Cell Endocrinol; 2015 May; 406():102-14. PubMed ID: 25725373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paternal Combined Botanicals Contribute to the Prevention of Estrogen Receptor-Negative Mammary Cancer in Transgenic Mice.
    Li S; Wu H; Chen M; Tollefsbol TO
    J Nutr; 2023 Jul; 153(7):1959-1973. PubMed ID: 37146973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells.
    Kala R; Tollefsbol TO
    PLoS One; 2016; 11(5):e0155057. PubMed ID: 27159275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
    Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel combinatorial approach using sulforaphane- and withaferin A-rich extracts for prevention of estrogen receptor-negative breast cancer through epigenetic and gut microbial mechanisms.
    Rahman MM; Wu H; Tollefsbol TO
    Sci Rep; 2024 May; 14(1):12091. PubMed ID: 38802425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hidden Markov model to identify combinatorial epigenetic regulation patterns for estrogen receptor α target genes.
    Bonneville R; Jin VX
    Bioinformatics; 2013 Jan; 29(1):22-8. PubMed ID: 23104890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate.
    Scandlyn MJ; Stuart EC; Somers-Edgar TJ; Menzies AR; Rosengren RJ
    Br J Cancer; 2008 Oct; 99(7):1056-63. PubMed ID: 18797454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic integrated analyses of methylomic and transcriptomic impacts of early combined botanicals on estrogen receptor-negative mammary cancer.
    Arora I; Li Y; Sharma M; Crowley MR; Crossman DK; Li S; Tollefsbol TO
    Sci Rep; 2021 May; 11(1):9481. PubMed ID: 33947955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.
    Yu-Rice Y; Jin Y; Han B; Qu Y; Johnson J; Watanabe T; Cheng L; Deng N; Tanaka H; Gao B; Liu Z; Sun Z; Bose S; Giuliano AE; Cui X
    Oncogene; 2016 Oct; 35(41):5400-5411. PubMed ID: 27041579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells.
    Riggs KA; Wickramasinghe NS; Cochrum RK; Watts MB; Klinge CM
    Cancer Res; 2006 Oct; 66(20):10188-98. PubMed ID: 17047084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice.
    Mai Z; Blackburn GL; Zhou JR
    Carcinogenesis; 2007 Jun; 28(6):1217-23. PubMed ID: 17234721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.
    Sharma D; Saxena NK; Davidson NE; Vertino PM
    Cancer Res; 2006 Jun; 66(12):6370-8. PubMed ID: 16778215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells.
    Fan P; Wang J; Santen RJ; Yue W
    Cancer Res; 2007 Feb; 67(3):1352-60. PubMed ID: 17283173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier.
    Ma W; Sun J; Xu J; Luo Z; Diao D; Zhang Z; Oberly PJ; Minnigh MB; Xie W; Poloyac SM; Huang Y; Li S
    Theranostics; 2020; 10(6):2463-2478. PubMed ID: 32194813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the CD59 Glycoprotein Precursor is Upregulated in an Estrogen Receptor-alpha (ER-α)-Negative and a Tamoxifen-Resistant Breast Cancer Cell Line In Vitro.
    Xiong H; Jin X; You C
    Med Sci Monit; 2018 Nov; 24():7883-7890. PubMed ID: 30391994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.